Seminars in Translational Oncology

TRON Seminars in
Translational Oncology

5 pm
Johannes Gutenberg University Medical Center
Lecture Hall, Building 708
Langenbeckstr. 1,
55131 Mainz

TRON hosts public seminars featuring national and international speakers to exchange knowledge and to facilitate cooperation. In addition to the opportunity of networking with speakers, the seminars provide a venue for colleagues from the University Medical Center Mainz and the Johannes Gutenberg-University Mainz and from the Rhein-Main Cluster Initiative on Individualized Immune Intervention (Ci3) to meet and discuss common interests with a view to potential collaborative projects.

You are cordially invited to join our discussion of hot topics and cutting-edge technologies in immune therapy.

March 16

Prof. Dr. Robin Shattock
Development of a vaccine against HIV
Department of Medicine, Imperial College London

November 17

Prof. Dr. Magnus von Knebel Doeberitz
The immune biology of microsatellite instability cancer: Towards a vaccine against HNPCC
Institute of Pathology at the University of Heidelberg

November 10

Prof. Eli Gilboa, Ph. D.
Inducing Neoantigens in Therapeutic and Prophylactic Cancer Immunotherapy
UM/Sylvester Comprehensive Cancer Center at the Miller School of Medicine, University of Miami

September 29

Dr. Tomáš Koblas
Diabetes, beta-cells and reprogramming with mRNA: potential cell-based therapy for diabetes
Clinical Islet Laboratory, Department of Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

September 08

Philip J. Santangelo, PhD
Characterizing mRNA-based therapeutics and vaccines: from single molecules to the whole body
Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University School of Medicine, Atlanta.

June 30

Dr. Markus Feuerer
Tissue-resident regulatory T cells
Helmholtz Young Investigator research group Immune Tolerance (D100), German Cancer Research Center (DKFZ), Heidelberg

June 09

Dr. Jaap Kwekkeboom & Dr. Dave Sprengers
Abrogation of the immunosuppressive tumor-microenvironment in Hepatocellular Carcinoma by targeting Treg and co-inhibitory pathways
Erasmus MC-University Medical Centre, Rotterdam

April 28

PD Dr. rer. nat. Adelheid Cerwenka
Exploiting Natural Killer cells for immunotherapy of cancer
Innate Immunity, German Cancer Research Center (DKFZ), Heidelberg

April 07

Prof. Dr. Günter Hämmerling
Regulation of tumor immunity by macrophage and eosinophils
Division of Molecular Immunology, German Cancer Research Center (DKFZ), Heidelberg

September 3

Dr. Matteo Iannacone, MD, PhD
“Immunosurveillance of the liver by intravascular effector CD8+ T cells”
Dynamics of Immune Responses, Division of Immunology
San Raffaele Scientific Institute, Milan, Italy

Juli 14

Prof. Yechezkel Barenholz
„Liposomal Drug Delivery“
School of Medicine-IMRIC-Biochemistry and Molecular Biology
The Hebrew University of Jerusalem, Israel

March 17

Prof. Dr. Jennifer Cochran
„Engineered Proteins for Visualizing and Treating Disease”
Cochran Lab, Stanford University, UK

March 12

Dr. Oscar Smrzka/Dr. Arne von Bonin
“Targeting IgE with therapeutic vaccines”
FFiRiS AG, Österreich

December 3 – 11:30AM, building 706!!!

Prof. Dr. Ulrich Kalinke
“New preclinical test system for an improved analysis of monoclonal antibody function”TWINCORE, Hannover, Germany

October 23

Prof. Twan Lammers
“Image-Guided Drug Delivery”Controlled Drug Delivery, Twente University, Faculty of Science and Technology, Enschede, The Netherlands

October 2

Dr. Aman
Integrated BioTherapeutics, Gaithersburg, MD, USA

September 18

Prof. Lehrach, Dr. Lange
Max Planck Institute for Molecular Genetics, Berlin

September 4

Prof. Kalinke
Institute for Experimental Infection Research,  TWINCORE, Hannover

August 20

Prof. Wolf
Translational Oncology at the Medical Univiersity of Cologne, Cologne
Prof. Büttner
Centre of Pathology at the Medical University of Cologne, Cologne

April 4

Prof. Joachim Koch
“Activating NK cell receptors in immunosurveillance of cancer cells”
Georg-Speyer-Haus, Frankfurt

January 30 – Building 505H!

Prof. Robin Shattock
“A shot in the arm towards effective HIV vaccines”
Imperial College London, UK

December 3 – 3:00-4:00 PM!

Prof. Dr. G. Hartmann
Dept. of Clinical Chemistry and Pharmacology at University Medical Center Bonn, Bonn, Germany

September 12

Prof. Dr. Sjoerd H. van der Burg and Dr. Thorbald van Hall
“TEIPP – T Cell Epitopes associated with Impaired Peptide Processing”
Dept. of Immunomonitoring and immunotherapy at LUMC (Leids Universitair Medisch Centrum), Leiden, Netherlands

August 29 – Postponed! New date will be announced soon.

Prof. A. Schwarting
ACURA Kliniken Rheinland-Pfalz, Bad Kreuznach, Germany

April 18 – 2:30-3:30 PM!

Jan Korbel
“Origin, complexity and impact of DNA structural rearrangements in cancer”
Group Leader – Genome Biology (EMBL) Heidelberg, Germany

April 11

Prof. Dr. Alexander Steinkasserer
“Induction of  regulatory T cells by soluble CD83 – Modulation of the immune system in autoimmunity and transplantation”
Head – Dept. of Immune Modulation at the Dept. of Dermatology, Erlangen, Germany

March 7

Prof. Dr. Philipp Beckhove
DKFZ, Division of Translational Immunology, Heidelberg, Germany

February 28

Prof. Ferdinando Nicoletti
“Animal Models”
OncoNOx
, Copenhagen, Denmark

February 21

Richard Scheuermann, PhD
“Unsupervised clustering and supervised classification for the automated analysis of flow cytometry data”
J. Craig Venter Institute
, Director of Informatics, San Diego, USA

January 31

Pierre van der Bruggen, PhD
“Regulation of T lymphocyte function in tumors”
de Duve Institute, Brussels, Belgium

January 17

Prof. Dr. med. Michael Platten
Department of Neurooncology, Ruprecht-Karls University Heidelberg, Heidelberg, Germany

December 13

Prof. Dr. Ada Kruisbeek
“Challenges and opportunities of a next generation dendritic cell cancer vaccine: pre-clinical and clinical overview”
Founder and CSO of DCPrime BV, Leiden, Netherlands

November 22

Matthew L. Albert and Milena Hasan
“Making biomarkers functional – a path towards personalized medicine”
Director of Dept of Immunology, Institut Pasteur, Paris, France

November 15

Prof. Dr. Michel Aguet
“Role of BCL9 proteins in Wnt-mediated stem cell maintenance”
National Center of Competence in Research (NCCR) “Molecular Oncology”, Lausanne, Switzerland

November 8 – postponed until 21.02.2013

Richard Scheuermann, PhD
J. Craig Venter Institute, Director of Informatics, San Diego, USA

October 11

Ronald Rooke, PhD
“Tetramere validation and new targets in oncology”
Transgene SA, Illkirch Graffenstaden Cedex, France

October 5, 2 PM – Change of date!

Prof. Dr. Ton Schumacher
“Dissecting cytotoxic T cell immunity in mice and men”
Head of Immunology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Netherlands

August 16 – 4 PM

Prof. Dr. Hans-Jürgen Thiesen
“Autoimmunity in Oncology: From epitope profiling to vaccination studies” Institute for Immunology, Universität Rostock, Germany

July 5

Prof. Dr. med. Dirk Jäger
“Tumor-host immune interactions and their prognostic/predictive significance”
Director Medical Oncology National Center for Tumor Diseases, University Medical Center Heidelberg, Germany

June 14

Dr. PhD. Vijay Tiwari
“Epigenetic Regulation of Cellular Differentiation”
Institute of Molecular Biology gGmbH, funded by the Boehringer Ingelheim Foundation, Mainz, Germany

May 31

Prof. Dr. med. Si­mo­ne Ful­da
“Targeting cell death pathways for cancer therapy”
In­sti­tu­te for Ex­pe­ri­men­tal Can­cer Re­se­arch in Pe­d­ia­trics, J.W. Goe­the Uni­ver­si­ty Hos­pi­tal Frank­furt am Main, Germany

May 10

Prof. Dr. Arne Skerra
“Anticalins: antibodies of a new kind through protein design”
Technische Universität München, Lehrstuhl für Biologische Chemie, Germany

May 3

Dr. Sonia Quaratino
“An insight on therapeutic cancer vaccines”
Merck KGaA, Darmstadt, Germany

April 19

Dr. Robert Holt
“Genomic analysis of tumour infection & immunity”
Canada’s Michael Smith Genome Sciences Centre, Vancouver, Canada

March 29

James Hadfield
“Targeted Resequencing: recent advances in amplicon sequencing and library prep technology”
Head of Genomics Core Facility, Cancer Research UK, Cambridge Research Institute, UK

March 15

Dr. Tobias Sjöblom
“Molecular cancergenetics”
Department of Immunology, Genetics and Pathology Uppsala University, Rudbeck Laboratory SE-751 85 Uppsala, Sweden

March 1

Prof. Dr. med. Hinrich Abken
“CARs with extraordinary performance: chimeric antigen receptor redirected T cells to fight cancer”
Tumorgenetik, Klinik 1 für innere Medizin und Zentrum für molekulare Medizin, Universität zu Köln, Germany

February 16

Dr. Anna Melissa Schlitter
“Pancreatic Cancer”
Institut für Pathologie Technische Universität München, Germany

February 9

Prof. Dr. Toni Cathomen
“Therapeutic Genome Engineering with Designer Nucleases”
Medizinische Hochschule Hannover, Institut für Experimentelle Hämatologie, Hannover, Germany

January 26

Prof. Dr. Zoltan Ivics
“Turning genomic junk into treasure: Genetic engineering with Sleeping Beauty transposons ”
Paul-Ehrlich-Institut, Experimental Research in the Division of Medical Biotechnology, Langen, Germany
(Click here for more information.)

December 8

Dr. Jerôme Galon
“Intratumoral Immune Reaction. A Novel Paradigm for Cancer”
Inserm U872, Integrative Cancer Immunology Laboratory, Paris, France

November 24

Prof. Mike Stratton
“Evolution of the Cancer Genome”
Wellcome Trust Sanger Institute, Cambridge, UK

November 3

Nicolae Ghinea, PhD
“Expression of FSH Receptor in tumor blood vessels: recent data  and perspectives”
National Institute of Health and Medical Research (INSERM), Paris, France

August 25

Dr. Kenneth Lundstrom
“Alphaviruses in Neuroscience and Gene Therapy“, PanTherapeutics, Lausanne, Switzerland